XML 57 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisitions (Details)
12 Months Ended
Jan. 01, 2024
Jun. 11, 2017
USD ($)
Payment
$ / shares
Nov. 02, 2016
USD ($)
Mar. 09, 2016
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
miraDry            
Business Acquisition [Line Items]            
Business acquisition agreement date         Jun. 11, 2017  
Business purchase price per share | $ / shares   $ 0.3149        
Cash   $ 18,700,000        
Contingent consideration   9,946,000        
Effective date of acquisition         Jul. 25, 2017  
Fair value of consideration transferred   $ 29,572,000        
Business combination contingent consideration payment period   1 year        
U.S. Rights to BIOCORNEUM            
Business Acquisition [Line Items]            
Cash       $ 6,859,000    
Contingent consideration       116,000    
Fair value of consideration transferred       $ 7,409,000    
U.S. Rights to BIOCORNEUM | Forecast            
Business Acquisition [Line Items]            
Number of years for future royalty payments to be paid 4 years 6 months          
Tissue Expander Portfolio from SSP            
Business Acquisition [Line Items]            
Cash     $ 4,950,000      
Contingent consideration     1,050,000      
Fair value of consideration transferred     $ 6,000,000      
Minimum | miraDry            
Business Acquisition [Line Items]            
Number of contingent payments | Payment   1        
Minimum | U.S. Rights to BIOCORNEUM            
Business Acquisition [Line Items]            
Estimated future payments due         $ 500,000  
Maximum | miraDry            
Business Acquisition [Line Items]            
Contingent consideration   $ 14,000,000        
Estimated future payments due   $ 14,000,000        
Maximum | Tissue Expander Portfolio from SSP            
Business Acquisition [Line Items]            
Estimated future payments due         2,000,000  
General & administrative expense | miraDry            
Business Acquisition [Line Items]            
Professional fees         3,100,000  
General & administrative expense | U.S. Rights to BIOCORNEUM            
Business Acquisition [Line Items]            
Professional fees           $ 200,000
General & administrative expense | Tissue Expander Portfolio from SSP            
Business Acquisition [Line Items]            
Professional fees         $ 100,000